Chest wrote:
Nasal CPAP has been shown to be effective in some patients with ICSA.[98] [99] The mechanism for improvement in these patients is not clear but may relate to prevention of inhibitory reflex mechanisms that arise during airway closure and potentially CPAP-induced increases in lung volume/O2 stores.
Another review of current treatments (O2, acetazolimide, theophylline, cpap, bipap) finds research supporting adaptive pressure support servo-ventilation (ASV) as having better clinical results and compliance for CSA than bipap:
Sleep Medicine Clinics wrote:
Overall compliance was significantly better with ASV than with CPAP, which decreased over time to less than 4 hours per night. Improved adherence to ASV may be attributed to the bilevel effect of pressure adjustments during respiratory cycles, but it also may reflect the overall effectiveness of treatment [60]. ASV also resulted in a statistically significant increase of 7% in LVEF; no such benefit was observed with CPAP. This lack of cardiovascular improvement with CPAP is in contrast to findings of multiple other studies reviewed earlier in this paper and may be explained by the lower overall airway pressure achieved.
Yes, cpap is used as a treatment of central apneas (more of a prevention than a cure). However, the technology I referred to is considered an "appropriate response" to central apnea and not a treatment considering the limitations of cpap.
References:
Eckert, D.J. Central sleep apnea: Pathophysiology and treatment. Chest - 01-FEB-2007; 131(2): 595-607
Connolly, T.A. Sleep-Related Breathing Disorder and Heart Disease--Central Sleep Apnea. Sleep Medicine Clin - March 2007; 2(1); 107-117
_________________
my cpap: resmed s8 autoset vantage
my mask: resmed mirage quattro

